Compare Injective (INJ) vs Obol (OBOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Obol — how do they compare? Injective trades at Rp76,508 (market cap Rp7,62T, Rp1,05T 24h volume), while Obol trades at Rp157.55 (market cap Rp30,1M, Rp51,72M 24h volume). The key difference: Injective is far larger — about 253156.1× Obol's market cap, and Obol's supply is capped (161,3M / 500M OBOL (33%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Obol for 16 Days on average.
| INJ | OBOL | |
|---|---|---|
Market Cap | Rp7,62T | Rp30,1M |
Volume (24h) | Rp1,05T | Rp51,72M |
Circulating Supply | 100M INJ | 161,3M / 500M OBOL (33%) |
Typical Hold Time | 37 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
OBOL is a low-market-cap cryptocurrency with a market cap of Rp30.1 million and a circulating supply of 161.3 million tokens out of a maximum 500 million, indicating a 33% circulation rate. The asset shows limited trading activity with an average hold time of 16 days. No recent price or volume data is available, suggesting low liquidity. There are no major protocol updates or ecosystem developments reported recently.
The outlook for OBOL is highly speculative due to its small market size and lack of recent data. Key opportunities include potential growth if the project gains adoption, but major risks involve extreme volatility, low liquidity, and minimal market presence. Investors should exercise caution and conduct thorough research before considering this asset.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Obol
Obol develops vital technologies that enhance Ethereum's decentralization and security, currently protecting billions in staked ETH. Its Distributed Validators (DVs) offer better uptime, lower risk, and improved performance compared to traditional staking. Using the middleware Charon, DVs enable Ethereum validators to function across multiple operators and machines, featuring threshold signing and distributed key generation for added resilience. The Obol Collective, powered by the OBOL Token, includes the largest decentralized operator ecosystem with major players like Lido and Blockdaemon. The Obol Stack simplifies the deployment of Ethereum nodes and other decentralized infrastructures, advancing the Ethereum economy.
Read more on OBOL →
